News

The binding domains were developed under a collaboration agreement between Eureka Therapeutics and MSK. The parties expect the BCMA CAR to enter human testing as early as 1H2017.

Also participating in this round were Sinopharm Capital, Humanwell Healthcare Fund. Existing investors Fosun Pharma, HOPU Investments and Everbright Limited Healthcare Fund participated in the financing. The Company

The companies have already signed contracts to exchange their respective animal health and consumer healthcare businesses. Sanofi will transfer ownership of the €11.4bn Merial animal health business to

Six patients have been administered MOR208 at the recommended dose (12mg/kg) in combination with lenalidomide during the safety run-in part of the L-MIND study. No unexpected safety signals

Under the terms of the agreement, APT employees will remain employed at the site, and the plant will continue to manufacture certain Astellas pharmaceutical products on a contract

Anda is currently the fourth-largest distributor of generic pharmaceuticals in the US. It delivers generic, brand, specialty, and over-the-counter pharmaceutical products from over 300 manufacturers to pharmacies. Under

The approval stipulates that patients whose tumors are EGFR or ALK positive should first receive an EFGR or ALK inhibitor, respectively, prior to treatment with Keytruda. The approved

AVROBIO will use the proceeds from this financing to accelerate development of its clinical stage programs in Fabry disease and acute myeloid leukemia (AML), and to expand its

The companies plan to engineer immune cells with fully human chimeric antigen receptors (CARs) and T-cell receptors (TCRs) directed to disease-specific cell surface antigens in order to enable